Stock surveillance & targeting

May 01, 2003
<p>How IR sleuthing has evolved from art to science</p>
Catherine Forte remembers the 'old days'. 'We would pore over reams of Technimetrics listings, highlighting any fund manager running enough money to fit our investment parameters,' recalls the IR veteran, now associate director of IR at biotech firm Genzyme.

Content Preview

to continue reading

Sign up to get stories direct to your inbox
logo-black logo-black